131 related articles for article (PubMed ID: 25150281)
1. A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.
Bhavsar NA; Bream JH; Meeker AK; Drake CG; Peskoe SB; Dabitao D; De Marzo AM; Isaacs WB; Platz EA
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2561-7. PubMed ID: 25150281
[TBL] [Abstract][Full Text] [Related]
2. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2017 Jun; 77(8):908-919. PubMed ID: 28317149
[TBL] [Abstract][Full Text] [Related]
3. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
[TBL] [Abstract][Full Text] [Related]
4. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.
Wang MH; Helzlsouer KJ; Smith MW; Hoffman-Bolton JA; Clipp SL; Grinberg V; De Marzo AM; Isaacs WB; Drake CG; Shugart YY; Platz EA
Prostate; 2009 Jun; 69(8):874-85. PubMed ID: 19267370
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic circulating anti-Müllerian hormone concentrations are not associated with prostate cancer risk.
Sklavos MM; Zhou CK; Pinto LA; Cook MB
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2597-602. PubMed ID: 25159294
[TBL] [Abstract][Full Text] [Related]
6. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.
Winchester DA; Gurel B; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Thompson IM; Xu J; Zheng SL; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; Drake CG; De Marzo AM; Platz EA
Prostate; 2016 May; 76(6):565-74. PubMed ID: 26771888
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections.
Ng PC; Li K; Wong RP; Chui K; Wong E; Li G; Fok TF
Arch Dis Child Fetal Neonatal Ed; 2003 May; 88(3):F209-13. PubMed ID: 12719394
[TBL] [Abstract][Full Text] [Related]
8. Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans.
Pine SR; Mechanic LE; Enewold L; Bowman ED; Ryan BM; Cote ML; Wenzlaff AS; Loffredo CA; Olivo-Marston S; Chaturvedi A; Caporaso NE; Schwartz AG; Harris CC
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):488-97. PubMed ID: 26711330
[TBL] [Abstract][Full Text] [Related]
9. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of nitrate and risk of prostate cancer: a prospective study.
Wu T; Wang Y; Ho SM; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1210-8. PubMed ID: 23677578
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.
Chan JM; Stampfer MJ; Ma J; Gann P; Gaziano JM; Pollak M; Giovannucci E
J Natl Cancer Inst; 2002 Jul; 94(14):1099-106. PubMed ID: 12122101
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis.
Prahalad S; Martins TB; Tebo AE; Whiting A; Clifford B; Zeft AS; McNally B; Bohnsack JF; Hill HR
Pediatr Rheumatol Online J; 2008 May; 6():8. PubMed ID: 18507862
[TBL] [Abstract][Full Text] [Related]
13. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Luhn P; Dallal CM; Weiss JM; Black A; Huang WY; Lacey JV; Hayes RB; Stanczyk FZ; Wentzensen N; Brinton LA
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1304-12. PubMed ID: 23696194
[TBL] [Abstract][Full Text] [Related]
14. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
15. High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcgammaR triggering.
Radstake TR; van Lent PL; Pesman GJ; Blom AB; Sweep FG; Rönnelid J; Adema GJ; Barrera P; van den Berg WB
Ann Rheum Dis; 2004 Jun; 63(6):696-702. PubMed ID: 15140777
[TBL] [Abstract][Full Text] [Related]
16. Circulating 25-hydroxyvitamin D, vitamin D binding protein and risk of advanced and lethal prostate cancer.
Yuan C; Shui IM; Wilson KM; Stampfer MJ; Mucci LA; Giovannucci EL
Int J Cancer; 2019 May; 144(10):2401-2407. PubMed ID: 30411792
[TBL] [Abstract][Full Text] [Related]
17. Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.
Black A; Pinsky PF; Grubb RL; Falk RT; Hsing AW; Chu L; Meyer T; Veenstra TD; Xu X; Yu K; Ziegler RG; Brinton LA; Hoover RN; Cook MB
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2374-82. PubMed ID: 25178985
[TBL] [Abstract][Full Text] [Related]
18. Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.
Lai GY; Helzlsouer KJ; Clipp SL; Rifai N; Platz EA
Cancer Prev Res (Phila); 2010 Oct; 3(10):1334-41. PubMed ID: 20858760
[TBL] [Abstract][Full Text] [Related]
19. Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence.
Dluzniewski PJ; Wang MH; Zheng SL; De Marzo AM; Drake CG; Fedor HL; Partin AW; Han M; Fallin MD; Xu J; Isaacs WB; Platz EA
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1774-82. PubMed ID: 22859398
[TBL] [Abstract][Full Text] [Related]
20. No association of plasma levels of adiponectin and c-peptide with risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Stevens VL; Jacobs EJ; Sun J; Gapstur SM
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):890-2. PubMed ID: 24585409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
